Medical Marijuana Inc.’s HempMedsPX Named Sponsor of High Times Medical Cannabis Cup in Seattle, Washington

HempMedsPX Will Exhibit Hemp-Based Cannabidiol (CBD) Products at Seattle US Cannabis Cup

SAN DIEGO, Aug. 28, 2013 (GLOBE NEWSWIRE) — Medical Marijuana Inc. (OTC Pink:MJNA) is pleased to inform shareholders and the general public that HempMedsPX—a corporate portfolio company of Medical Marijuana Inc. and the exclusive master distributor and contracted marketing company for CannaVest Corp. and Medical Marijuana Inc.—will be showcasing four cannabidiol (CBD) products from four separate portfolio companies at the High Times Medical Cannabis Cup in Seattle, Washington September 7-8, 2013.

The High Times Medical Cannabis Cup is a showcase of the finest medical cannabis and medical cannabis products worldwide. The best cannabis strains, concentrates, edibles, and more will be judged by a panel of industry experts. HempMedsPX will enter flagship products CanChew and Real Scientific Hemp Oil (RSHO) and two prototype products, CBD Gold and CBD Simple, for judging. These four products will be entered into the competition as follows:

CanChew CBD gum by CanChew Biotechnologies in the Edibles Category

Real Scientific Hemp Oil (RSHO) by US Hemp Oil in the Concentrate Category

CBD Gold by CannaVest Corp. in the Concentrate Category

CBD Simple by PhytoSPHERE Systems in the Concentrate Category
HempMedsPX is a sponsor of the two-day expo, which will also include cannabis industry seminars, question and answer panels with leaders of the medical cannabis movement, cannabis celebrities, live music and more.

“As cannabis enters the mainstream, we’re providing the industry with innovative and standardized hemp CBD products,” said Charles Vest, Director of Communications for HempMedsPX. “The High Times Magazine staff has been overwhelmingly supportive of our efforts, and we can’t think of a better introduction to the broader cannabis market than the Medical Cannabis Cup event.”

Chris Boucher, Vice President of Product Development for HempMedsPX and hemp industry pioneer, stated: “We want to support the entire cannabis industry, and that includes both marijuana and hemp. As cannabidiol’s profile is raised by people like Dr. Sanjay Gupta, this is a major opportunity to showcase the capabilities of hemp-based cannabinoids.”

The two-day event will be held at Fremont Studios in Seattle, Washington on September 7-8, 2013. For more information, please visit or

About HempMedsPX

HempMedsPX is the master distributor and contracted marketing company for the CannaVest Corp. (OTC:CANV) and Medical Marijuana, Inc. (OTC Pink:MJNA) portfolio of products, including their revolutionary hemp-based cannabidiol (CBD) products. HempMedsPX offers mainstream marketing, sales, customer service, and logistics for the cannabis industry. In addition to handling sales and distribution, HempMedsPX is the communication hub for the Medical Marijuana Inc. portfolio of companies.

About Medical Marijuana, Inc.

Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally friendly, economically sustainable businesses, while increasing shareholder value. For more information, please visit the company’s website at:

About CannaVest Corp.

CannaVest Corp. is in the business of investing and developing hemp-based cannabinoid companies. CannaVest Corp. also develops, produces, markets and sells end-consumer products to the nutraceutical industry containing the hemp plant extract, cannabidiol (CBD). Additionally, the company resells—to third parties—raw product acquired by CannaVest Corp. pursuant to the company’s supply relationships in Europe. CannaVest Corp. seeks to take advantage of an emerging worldwide trend to re-energize the production of industrial hemp and to foster its many uses for consumers. Cannabinoids (cannabidiol/CBD) are natural constituents of the hemp plant and CBD is derived from hemp stalk and seed. Additional information is available from or by visiting

About CanChew Biotechnologies

CanChew Biotechnologies focuses on the treatment of pain and other medical disorders with the application of chewing gum-based cannabis/cannabinoid medical products as well as food and nutraceutical products for general well-being.

The company is focused on the R&D and execution of their clinical development plan and potential out-licensing of their technology. Clinical development focuses on the R&D of the formulation, production and the development of chewing gum-based products for the treatment of conditions like pain, nausea and vomiting, anorexia, spasticity and various other medical issues. For more information on the company, visit

About Cannagum Marketing Group

Cannagum Marketing Group, a wholly-owned subsidiary of CanChew Biotechnologies, was incorporated to sell, market, and distribute CanChew gum. The company was formed to comply with federal regulations that require the company to clearly distinguish CanChew gum, a food product sold without claims, from MedChewRX, a pharmaceutical product that is in development by CanChew Biotechnologies. For more information, please visit

About PhytoSPHERE Systems

PhytoSPHERE Systems is a global phytocannabinoid biotechnology company based in San Diego, California with an exclusive license for use by CannaVest Corp. (OTC:CANV). The company utilizes advanced cultivation methods and state-of-the-art processing technology leading to development of pharmaceutical, nutraceutical and food products.

PhytoSPHERE Systems, the manufacturer of the CBD-rich hemp oil used in Real Scientific Hemp Oil (RSHO), has developed special cultivars (similar to “strains”) that produce hemp that is especially rich in CBD, making it possible for PhytoSPHERE to offer all-natural products with high concentrations of hemp-based CBD. For more information, visit:

About US Hemp Oil

US Hemp Oil seeks to develop the United States industrial hemp industry. The company is dedicated to the procurement, processing, marketing and distribution of bulk wholesale hemp seed, hemp oil, protein, food and hemp body care products. US Hemp Oil currently has three brands: RSHO, Cibaderm, and Cibdex. US Hemp Oil is determined to bring hemp products into the mainstream by creating greater public awareness of and media exposure for the exceptional nutritional profile of hemp and the environmental benefits of growing industrial hemp. For more information, please visit:


These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.


This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. and CannaVest Corp. to be materially different from the statements made herein.


Medical Marijuana, Inc., CannaVest Corp., and HempMedsPX do not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell and distribute hemp-based products and are involved with Federally Legal Distribution of Medical Marijuana based products within certain international markets.

For further information, please contact:
Investor relations contact:
Stuart T. Smith
SmallCapVoice.Com, Inc.
P. 512-267-2430
F. 512-267-2530
AIM: SmallCapVoice7

Corporate contact:
Medical Marijuana, Inc.
Toll Free: 888-OTC-MJNA (888-682-6562)